TRANK1 and schizophrenia: In addition, high levels of anti-TRANK1 (thioredoxin peroxidase-related activator of NF-κB and c-Jun N-terminal kinase) IgG were demonstrated in FEP patients, which could probably serve as a biomarker for identifying patients with schizophrenia [139].